- Report
- August 2026
- 131 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- August 2026
- 276 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- August 2026
- 144 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- March 2026
- 150 Pages
Global
From €3366EUR$3,750USD£2,882GBP
- Report
- November 2025
- 150 Pages
Global
From €3366EUR$3,750USD£2,882GBP
- Report
- May 2026
- 200 Pages
Global
From €2504EUR$2,789USD£2,143GBP
- Report
- April 2026
- 148 Pages
Global
From €2692EUR$2,999USD£2,305GBP
€3590EUR$3,999USD£3,073GBP
- Report
- March 2026
- 149 Pages
Global
From €2692EUR$2,999USD£2,305GBP
€3590EUR$3,999USD£3,073GBP
- Report
- April 2026
- 305 Pages
Global
From €2244EUR$2,500USD£1,921GBP
- Report
- January 2026
- 286 Pages
Global
From €2244EUR$2,500USD£1,921GBP
- Report
- July 2026
- 110 Pages
Global
From €4264EUR$4,750USD£3,651GBP
- Report
- July 2026
- 70 Pages
Global
From €4264EUR$4,750USD£3,651GBP
- Report
- April 2026
- 180 Pages
Global
From €4264EUR$4,750USD£3,651GBP
- Report
- July 2026
- 160 Pages
Global
From €3726EUR$4,150USD£3,189GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2504EUR$2,789USD£2,143GBP
- Report
- May 2026
- 150 Pages
Global
From €2423EUR$2,699USD£2,074GBP
- Report
- May 2026
- 400 Pages
Global
From €4443EUR$4,949USD£3,803GBP
- Report
- May 2026
- 400 Pages
Global
From €3473EUR$3,869USD£2,973GBP
- Report
- July 2026
- 160 Pages
Global
From €3726EUR$4,150USD£3,189GBP
- Report
- July 2026
- 160 Pages
Global
From €3726EUR$4,150USD£3,189GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more